Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
The specific topic, "Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants - New Perspectives In Parkinson`S Disease Therapy," was chosen in light of accumulating neurobiological evidence indicating that, in addition to exogenous neurotoxins (e.g., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [MPTP]), endogenous compounds may play an important role in the most common neurodegenerative disorders (e.g., Parkinson`s disease). Two groups of amine related compounds, which appeared chemically like MPTP, were detected in human brain and cerebrospinal fluid (CSF): ß-carbolines (BCs) and tetrahydroisoquinolines (TIQs). These are heterocyclic compounds formed endogenously from phenylalanine/tyrosine (TIQs) and tryptophan, tryptamine, and 5-hydroxytryptamine (BCs), respectively and exert a wide spectrum of psychopharmacological and behavioral effects. The TIQs and BCs may bind to their own high affinity sites on neuronal membranes associated with or located close to the receptors of neurotransmitters. Research on TIQs and BCs is stimulated also by their possible role in pathological conditions, especially parkinsonism and alcoholism. Recently, clinical interest has been spurred by their role as neuroprotective, and even neurorestorative, anticonvulsant and antiaddictive, substances. In this book we are going to summarize, for the first time, the results from behavioral, neurochemical and molecular experiments, which demonstrate a wide spectrum of TIQs and BCs effects - from their rather mild neurotoxic actions to the important neuroprotective and antiaddictive properties. Additionally, the recent results of experimental studies in vivo have allowed a much better understanding and simultaneous comparison of the neurochemical and molecular mechanisms underlying the neuroprotective and neurotoxic actions of endogenous TIQs and BCs and have pointed to the possibility of their therapeutic applications in neurodegenerative diseases such as Parkinson's disease. von Antkiewicz-Michaluk, Lucyna und Rommelspacher, Hans
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
- Gebunden
- 346 Seiten
- Erschienen 2017
- Wiley-VCH
- Gebunden
- 240 Seiten
- Erschienen 2021
- Wiley-VCH
- Gebunden
- 202 Seiten
- Erschienen 2011
- W. Kohlhammer GmbH
- paperback
- 751 Seiten
- Erschienen 2016
- Springer
- Gebunden
- 1043 Seiten
- Erschienen 2020
- Springer
- Kartoniert
- 252 Seiten
- Erschienen 2000
- Thieme
- hardcover
- 789 Seiten
- Erschienen 1997
- Springer
- Hardcover
- 512 Seiten
- Erschienen 1999
- Academic Press
- Kartoniert
- 296 Seiten
- Erschienen 2022
- Springer
- cd_rom -
- Erschienen 2016
- Cornelsen Verlag
- hardcover
- 1296 Seiten
- Erschienen 2009
- Humana
- Gebunden
- 542 Seiten
- Erschienen 2022
- Wiley-VCH
- Kartoniert
- 368 Seiten
- Erschienen 2010
- Spektrum Akademischer Verlag




